[1]
Sverdloff, C.E., Marcondes Rezende, V., Rebelo Galvinas, P.A., Araújo Pinto, G., Nerath Bonanato, L. and Bastos Canton Pacheco, F. 2023. Bioequivalence/bioavailability study of a new formulation of imatinib mesylate 100 mg coated tablets versus Glivec® in Brazilian healthy male volunteers in fed state. Revista Brasileira de Cancerologia. 69, 4 (Dec. 2023), e–154060. DOI:https://doi.org/10.32635/2176-9745.RBC.2023v69n4.4060.